Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael R Mulvey

Showing results (1-10 of 216) with videos related to

Pageof 22
Sort By:
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 18, 2009
Antimicrobial resistance in hospitals: how concerned should we be?Michael R Mulvey, Andrew E Simor
The Journal of Antimicrobial Chemotherapy|June 1, 2006
OXA-1 is OXA-30 is OXA-1David A Boyd, Michael R Mulvey
Antimicrobial Agents and Chemotherapy|August 19, 2009
TEM-168, a heretofore laboratory-derived TEM beta-lactamase variant found in an Escherichia coli clinical isolateMichael R Mulvey, David A Boyd
Scandinavian Journal of Infectious Diseases|July 27, 2007
Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinamLindsay E Nicolle, Michael R Mulvey
Sexually Transmitted Diseases|April 18, 2018
Utilization of Nucleic Acid Amplification Testing Samples for Antimicrobial Resistance Surveillance in Remote Canadian CommunitiesMichael R Mulvey, Irene Martin, Tom Wong
The New England Journal of Medicine|December 16, 2016
Multiple Variants of Klebsiella pneumoniae Producing Carbapenemase in One PatientMichael R Mulvey, Louis-Patrick Haraoui, Yves Longtin
Antimicrobial Agents and Chemotherapy|May 20, 2015
Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeaeAmrita Bharat, Walter Demczuk, Irene Martin, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) geneDavid A Boyd, Mark A Miller, Michael R Mulvey
Canadian Journal of Microbiology|February 14, 2024
Do we still need Illumina sequencing data? Evaluating Oxford Nanopore Technologies R10.4.1 flow cells and the Rapid v14 library prep kit for Gram negative bacteria whole genome assembliesNicole Lerminiaux, Ken Fakharuddin, Michael R Mulvey, et al.
Molecular Microbiology|March 9, 2005
The Salmonella genomic island 1 is an integrative mobilizable elementBenoît Doublet, David Boyd, Michael R Mulvey, et al.
Pageof 22

Showing results (1-10 of 216) with videos related to

Sort By:
Pageof 22
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 18, 2009
Antimicrobial resistance in hospitals: how concerned should we be?Michael R Mulvey, Andrew E Simor
The Journal of Antimicrobial Chemotherapy|June 1, 2006
OXA-1 is OXA-30 is OXA-1David A Boyd, Michael R Mulvey
Antimicrobial Agents and Chemotherapy|August 19, 2009
TEM-168, a heretofore laboratory-derived TEM beta-lactamase variant found in an Escherichia coli clinical isolateMichael R Mulvey, David A Boyd
Scandinavian Journal of Infectious Diseases|July 27, 2007
Successful treatment of ctx-m ESBL producing Escherichia coli relapsing pyelonephritis with long term pivmecillinamLindsay E Nicolle, Michael R Mulvey
Sexually Transmitted Diseases|April 18, 2018
Utilization of Nucleic Acid Amplification Testing Samples for Antimicrobial Resistance Surveillance in Remote Canadian CommunitiesMichael R Mulvey, Irene Martin, Tom Wong
The New England Journal of Medicine|December 16, 2016
Multiple Variants of Klebsiella pneumoniae Producing Carbapenemase in One PatientMichael R Mulvey, Louis-Patrick Haraoui, Yves Longtin
Antimicrobial Agents and Chemotherapy|May 20, 2015
Effect of Variants of Penicillin-Binding Protein 2 on Cephalosporin and Carbapenem Susceptibilities in Neisseria gonorrhoeaeAmrita Bharat, Walter Demczuk, Irene Martin, et al.
Antimicrobial Agents and Chemotherapy|February 24, 2006
Enterococcus gallinarum N04-0414 harbors a VanD-type vancomycin resistance operon and does not contain a D-alanine:D-alanine 2 (ddl2) geneDavid A Boyd, Mark A Miller, Michael R Mulvey
Canadian Journal of Microbiology|February 14, 2024
Do we still need Illumina sequencing data? Evaluating Oxford Nanopore Technologies R10.4.1 flow cells and the Rapid v14 library prep kit for Gram negative bacteria whole genome assembliesNicole Lerminiaux, Ken Fakharuddin, Michael R Mulvey, et al.
Molecular Microbiology|March 9, 2005
The Salmonella genomic island 1 is an integrative mobilizable elementBenoît Doublet, David Boyd, Michael R Mulvey, et al.
Pageof 22